| Financial Year |
March 31 2023 |
| Monetary Funds |
208,431,080.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
100,364,671.52 |
| Accounts Receivable |
323,770,814.12 |
| Advances to Suppliers |
95,717,016.61 |
| Other Receivables |
12,699,523.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
608,944,853.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
7,661,231.65 |
| Other Current Assets |
46,334,479.58 |
| Total Current Assets |
1,519,994,280.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,002,951.43 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
88,237,522.42 |
| Under-construction Projects |
14,052,492.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
711,109.99 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
47,295,972.97 |
| R&D expenses |
33,598,663.63 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,759,800.06 |
| Deferred Income Tax Assets |
35,614,890.76 |
| Other Non-Current Assets |
4,696,092.78 |
| Sub-Total of Non-Current Assets |
269,354,333.05 |
| Total Assets |
1,789,348,614.00 |
| Short-Term Loans |
460,517,717.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,935,853.24 |
| Accounts Payable |
337,850,085.01 |
| Accounts Received In Advance |
35,735,410.35 |
| Employee Compensation Payable |
10,199,268.33 |
| Taxes Payable |
721,372.21 |
| Interest Payable |
-- |
| Dividend Payable |
349,394.80 |
| Other payables |
26,540,533.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,100,440.21 |
| Other Current Liabilities |
12,389,124.24 |
| Sub-Total of Current Liabilities |
1,289,948,022.17 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
800,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
52,978,290.41 |
| Total Liabilities |
1,342,926,312.58 |
| Paid-In Capital(Or Share Stock) |
108,080,000.00 |
| Capital Surplus |
376,484,244.92 |
| Surplus Reserve |
21,410,785.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-25,943,520.59 |
| Minority Stockholder's Interest |
-32,848,128.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
479,270,430.09 |
| Owner's Equity（Stockholder's Equity） |
446,422,301.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,789,348,614.00 |
